Hillhouse Investment Management, Ltd. 的 Form 4 申報
BeOne Medicines Ltd.（ONC），2023/6/12 申報
- 申報編號
- 0000902664-23-003537
- 申報時間
- 2023/6/12 21:57 ET
- 交易日
- 2023/6/8-6/12
- 申報延遲
- 4 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 5 筆非衍生性交易。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Hillhouse Investment Management, Ltd.CIK 0001510589 | 持股 10% 以上大股東 |
| HHLR Advisors, Ltd.CIK 0001762304 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/6/8 | Ordinary Shares | S賣出處分 | −1,163,825 | $218.14F1 | −$253,881,789.95 | 145,879,233 | 間接 | 價格異常 |
| 2023/6/9 | Ordinary Shares | S賣出處分 | −213,700 | HKD 130.35F2,F3照申報以 HKD 計價 | −HKD 27,856,286.51 | 145,665,533 | 間接 | 價格異常 |
| 2023/6/9 | Ordinary Shares | S賣出處分 | −328,952 | $217.02F1 | −$71,388,603.82 | 145,336,581 | 間接 | 價格異常 |
| 2023/6/12 | Ordinary Shares | S賣出處分 | −281,400 | HKD 130.83F2,F4照申報以 HKD 計價 | −HKD 36,816,181.08 | 145,055,181 | 間接 | 價格異常 |
| 2023/6/12 | Ordinary Shares | S賣出處分 | −968,812 | $213.91F1 | −$207,240,996.95 | 144,086,369 | 間接 | 價格異常 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The shares sold were in the form of ADS. The reported price is the price of each ADS sold, the price was paid in USD. Each ADS represents 13 Ordinary Shares.
表 I 有 3 筆交易的價格引用這則附註。
- F2
The ordinary shares were sold through the Stock Exchange of Hong Kong, the price was paid in HKD.
表 I 有 2 筆交易的價格引用這則附註。
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from HKD130.2787 to HKD130.550, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ordinary shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from HKD131.7943 to HKD131.0298 inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ordinary shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。